*Pathology Queensland, Royal Brisbane and Women’s Hospital
†School of Medicine, University of Queensland
‡Familial Cancer Laboratory, Queensland Institute of Medical Research
¶¶Envoi Specialists Pathologist, Herston, QLD
§Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, School of Population Health, The University of Melbourne, Carlton, Vic.
‡‡School of Paediatrics and Child Health, University of Western Australia, Nedlands, WA
§§Genetic Services of Western Australia, Subiaco, WA, Australia
∥Department of Internal Medicine, Division of Human Genetics, Comprehensive Cancer Center
¶Department of Pathology, The Ohio State University, Columbus, OH
#Zane Cohen Centre for Digestive Diseases
††Samuel Lunenfeld Research Institute, Mount Sinai Hospital
**Cancer Care Ontario, Toronto, ON, Canada
∥∥Familial GI Cancer Registry, Auckland City Hospital
***Department of Gastroenterology, Middlemore Hospital, Auckland, New Zealand
##Department of Cellular Pathology, St Mark’s Hospital, Harrow, UK
Conflicts of Interest and Source of Funding: The authors have disclosed that they have no significant relationships with, or financial interest in, any commercial companies pertaining to this article. Supported by grants from the Cancer Council Queensland, the National Health and Medical Research Council, and the National Cancer Institute 1R01CA123010 (Genetics of Serrated Neoplasia). J.P.Y. is a Cancer Council Queensland Senior Research Fellow. C.R. is the Jass Pathology Fellow (2010–2011).
Correspondence: Christophe Rosty, MD, PhD, Royal Brisbane and Women’s Hospital, Pathology Queensland, Block 7, Level 2, Herston, Qld 4006, Australia (e-mail: [email protected]).
